These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1363485)

  • 21. Regulation of prefrontal cortical dopamine release by dopamine receptor agonists and antagonists.
    Santiago M; Machado A; Cano J
    Eur J Pharmacol; 1993 Aug; 239(1-3):83-91. PubMed ID: 7901031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of a D2 receptor increases electrical coupling between retinal horizontal cells by inhibiting dopamine release.
    Harsanyi K; Mangel SC
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9220-4. PubMed ID: 1357661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential regulation of release of acetylcholine in the striatum in mice following continuous exposure to selective D1 and D2 dopaminergic agonists.
    Wang HY; Zhou LW; Friedman E; Weiss B
    Neuropharmacology; 1993 Jan; 32(1):85-91. PubMed ID: 8094235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Release-regulating dopamine autoreceptors in human cerebral cortex.
    Fedele E; Andrioli GC; Ruelle A; Raiteri M
    Br J Pharmacol; 1993 Sep; 110(1):20-2. PubMed ID: 8106101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of D1 and D2 receptors in the heightened locomotion induced by direct and indirect dopamine agonists in rats with hippocampal damage: an animal analogue of schizophrenia.
    Mittleman G; LeDuc PA; Whishaw IQ
    Behav Brain Res; 1993 Jun; 55(2):253-67. PubMed ID: 8102851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine D2-receptors mediate hypothermia in mice: ICV and IP effects of agonists and antagonists.
    Nunes JL; Sharif NA; Michel AD; Whiting RL
    Neurochem Res; 1991 Oct; 16(10):1167-74. PubMed ID: 1686637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Supersensitization of intrastriatal dopamine receptors involved in opposite regulation of acetylcholine release in Parkinson's model rats.
    Sato K; Ueda H; Okumura F; Misu Y
    Neurosci Lett; 1994 May; 173(1-2):59-62. PubMed ID: 7936424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of both D-1 and D-2 dopamine receptors may induce catalepsy in mice.
    Zarrindast MR; Habibi-Moini S
    Gen Pharmacol; 1991; 22(6):1023-6. PubMed ID: 1687392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of D1 and D2 agonists in primates withdrawn from long-term treatment with haloperidol: the potential role of dopamine D1 receptors in dyskinesia.
    Lublin H; Gerlach J; Peacock L
    Clin Neuropharmacol; 1992 Dec; 15(6):448-58. PubMed ID: 1362136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiological verification of the presence of D1 and D2 dopamine receptors within the ventral pallidum.
    Napier TC; Maslowski-Cobuzzi RJ
    Synapse; 1994 Jul; 17(3):160-6. PubMed ID: 7974198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-activation of D1- and D2-like receptors is unnecessary for stimulated motor behavior in rats depleted of dopamine during development.
    Byrnes EM; Abrams D; Bruno JP
    Behav Brain Res; 1994 Apr; 61(2):205-14. PubMed ID: 7913605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-training dopamine receptor agonists and antagonists affect memory storage in mice irrespective of their selectivity for D1 or D2 receptors.
    Castellano C; Cestari V; Cabib S; Puglisi-Allegra S
    Behav Neural Biol; 1991 Nov; 56(3):283-91. PubMed ID: 1684703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
    LaHoste GJ; Marshall JF
    Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM; Bruno JP
    Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of selective D1 and D2 dopamine agonists on cockroach salivary gland acinar cells in vitro.
    Evans AM; Green KL
    Br J Pharmacol; 1991 Dec; 104(4):787-92. PubMed ID: 1687366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward.
    Ikemoto S; Glazier BS; Murphy JM; McBride WJ
    J Neurosci; 1997 Nov; 17(21):8580-7. PubMed ID: 9334429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polydipsia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists.
    Mittleman G; Rosner AL; Schaub CL
    J Pharmacol Exp Ther; 1994 Nov; 271(2):638-50. PubMed ID: 7965779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin.
    Engber TM; Boldry RC; Kuo S; Chase TN
    Brain Res; 1992 May; 581(2):261-8. PubMed ID: 1356580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contralateral turning elicited by unilateral stimulation of dopamine D2 and D1 receptors in the nucleus accumbens of rats is due to stimulation of these receptors in the shell, but not the core, of this nucleus.
    Koshikawa N; Kitamura M; Kobayashi M; Cools AR
    Psychopharmacology (Berl); 1996 Aug; 126(3):185-90. PubMed ID: 8876017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.